On 2025-05-01, Phathom Pharmaceuticals, Inc. (PHAT) announced earnings per share of $-1.15 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-1.16.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.86 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-01 | 2025-03-31 | $-1.16 | $-1.15 |
| 2025-03-06 | 2024-12-31 | $-1.08 | $-0.88 |
| 2024-11-07 | 2024-09-30 | $-1.57 | $-1.32 |
| 2024-08-08 | 2024-06-30 | $-1.39 | $-1.35 |
| 2024-05-09 | 2024-03-31 | $-1.43 | $-1.42 |
| 2024-03-07 | 2023-12-31 | $-0.92 | $-0.80 |
| 2023-11-09 | 2023-09-30 | $-0.95 | $-0.76 |
| 2023-08-10 | 2023-06-30 | $-0.95 | $-0.84 |
| 2023-05-10 | 2023-03-31 | $-1.34 | $-0.89 |
| 2023-02-28 | 2022-12-31 | $-1.50 | $-1.33 |
| 2022-11-08 | 2022-09-30 | -- | $-1.32 |
| 2022-08-02 | 2022-06-30 | -- | $-1.33 |
| 2022-05-10 | 2022-03-31 | -- | $-1.07 |
| 2022-03-01 | 2021-12-31 | $-0.86 | $-0.95 |
| 2021-11-08 | 2021-09-30 | $-0.78 | $-0.98 |
| 2021-08-10 | 2021-06-30 | $-1.07 | $-1.00 |
| 2021-05-11 | 2021-03-31 | $-1.11 | $-0.96 |
| 2021-03-30 | 2020-12-31 | $-0.93 | $-1.58 |
| 2020-11-10 | 2020-09-30 | $-0.68 | $-1.02 |
| 2020-08-06 | 2020-06-30 | -- | $-0.64 |
| 2020-05-12 | 2020-03-31 | $-0.59 | $-0.62 |
| 2019-11-25 | 2019-09-30 | $-0.67 | $-1.07 |